Climb Bio, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold CLYM, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
10
Funds holding
$8023556
Total value held
Buying
8 added/new · 2 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $2751296 | 401649 | +12340 | +3.17% |
| 2 | Morgan Stanley | $1604148 | 234182 | +85644 | +57.66% |
| 3 | Goldman Sachs Group Inc | $1027295 | 149970 | -74913 | -33.31% |
| 4 | State Street Corp | $904200 | 132000 | +3100 | +2.40% |
| 5 | Northern Trust Corp | $876143 | 127904 | +3234 | +2.59% |
| 6 | Bank Of America Corp /De/ | $362509 | 52921 | +47858 | +945.25% |
| 7 | Barclays Plc | $335211 | 48936 | — | NEW BUY |
| 8 | Raymond James Financial Inc | $121430 | 17727 | — | NEW BUY |
| 9 | Citigroup Inc | $41324 | 10331 | -319217 | -96.87% |
| 10 | Royal Bank Of Canada | $0 | 79 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.